As a preferred partner, we seamlessly integrate external innovation with internal capabilities to deliver transformative outcomes.
PARTNERS
02
SINCE
2022
PARTNER 01
Selleck (China)
Since 2022, we have established substantial collaborations with Selleck (China) in the realms of compound library synthesis and hit compound optimization.
Compound library synthesis
Hit optimization
COMPOUND LIBRARYSCHEMATIC
PARTNER 02
DEFUSE
Innovation Drug Discovery Platform
Focused on targeted protein degradation to conquer “undruggable” targets and establish new paradigms as the partner of choice.
Partner where revolutionary innovation drug discovery platform de-risks investment while avoiding high cost of late-stage assets, with differentiated ability to integrate early-stage external innovation with internal capabilities to co-develop and deliver.
DEFUSE